The Advanced Wound Care Summit is the first industry-led forum focused on delivering innovative wound care treatments to patients. Expect to hear from, and discuss with, world leaders of wound care research who are driving the development of novel biomaterials, remote-monitoring devices, and digital health management solutions. Find out how C-level Executives, VPs and Directors of R&D are tackling the most pressing industry challenges and seizing new growth opportunities. Whether an executive, investor, researcher or healthcare professional, this meeting offers an empowering environment that allows you to make wound care decisions with confidence. 

Read on advancedwoundcareusa.com

It's a chance for senior executives to address shared challenges around innovative product development, build meaningful partnerships, and sharpen their R and D and commercial strategies.

Whether an established wound care company, an emerging start-up, an SME, a regulator, a payer, or key opinion leader, this event serves your strategic and commercial goals.

To take this chance to uncover how leading figures are leveraging novel clinical trial designs, addressing reimbursement challenges surrounding skin substitute products, progressing next generation diagnostic innovations, and much more.

Read on go.evvnt.com

INOVINE Scientific meetings is overwhelmed to announce the commencement of “5th World Congress on Diabetes & Endocrinology” to be held during July 12-13, 2023, Paris, France. The upcoming conference will be organized around the theme “Novel therapeutic approaches for prevention of diabetes and exploring the diabetic complications”.

The main objective of Diabetes congress 2023 is to promote awareness about diabetes and risk associated with it along with endocrinology and its impact on health and will educate and strengthen recent research on the several causes, results, treatment, and prevention of diabetes, this conference encourages the involvement of researchers, scientists and to highlight their role, this will help to connect active researchers and practitioners from diverse disciplines.

The conference is intended in a way to communicate university circles and commerce on a single podium nurturing new research collaborations. It folds reputed scientists, researchers and faculty from universities and research institutions, Obesity specialists, Diabetic surgeons, Weight loss specialists, physicians, endocrinologists, nutritionists, dietitians, health care personnel, CEO’s, Presidents of industries, business delegates, young researchers and talented student populations under a solitary gable catalyzing information exchange for the advancement of research in the field of Endocrinology and Diabetes.

Read on diabetes.inovineconferences.com

PDA 2023 Cell and Gene Pharmaceutical Products Conference will take place on 12-13 July 2023 at Ochanomizu Solacity Conference Hall, Tokyo. Themed "The Present and Future of Manufacturing and Quality of Cell-based Products," the program will feature prominent persons from industry, government, and academia. They will share their knowledge through lectures on the current state and future of design and management from the three aspects of sterility, process, and quality in the manufacture of Cell-based pharmaceutical products. Ample time will be allocated for the panel discussion and Q and A to allow for interaction between the faculty and attendees.

Read on go.evvnt.com

Over the last 12 months, we have seen many combination therapies enter Phase I and II trials with both successes and challenges, particularly in solid tumors. The FDA Modernization Act 2.0 passing has also steered biopharma away from animal models, empowering the preclinical and translational tumor models' space to continue innovating and decrease the translational gap into the clinic.

At the 11th Annual Tumor Models Boston Summit, you will gain practical insights into the latest updates through 25+ case studies across 2 dedicated tracks. Join us to learn from and meet pioneers in preclinical and translational targeted, combination oncology to advance your candidates to patients with optimized translatability, efficiency, and cost-effectiveness!

Read on tumor-models.com

With more than 300 trials in preclinical and clinical development actively using AAV as their vector of choice, the priority for any company working in this space is to ensure that each and every one of those therapies is the safest version it can be.

In this context, the 2nd Annual Optimizing AAV Safety Summit is returning in 2023, bringing together genetic therapy leaders across non-clinical development, clinical development, toxicology, biodistribution, and immunology who are all working to optimize the safety of their AAV-based drug products in their day-to-day.

Read on optimizing-aav-safety.com

From new tech to dental office staffing, there are many industry trends to stay on top of and continue learning about. Join this virtual event to get the latest insights and guidance you need around key industry insights and trends, lessons learned and predictions for the future.

Topics:

• Dental Practice M&A, Valuation Trends and More 
• DSO Growth and Headwinds for the Next 2 Years 
• The Evolution of DSOs: Big Growth Opportunities and Potential Challenges 
• Private Equity in Dentistry: Risks and Rewards

Read on events.beckershospitalreview.com

Discover effective strategies for oncology trial operations to ensure trials run smoothly and within budget. Arena International is delighted to announce Clinical Operations in Oncology Trials East will take place in Boston in July 2023! Bringing together clinical operations experts from oncology pharma and biotech sponsor companies on the East Coast alongside technology vendors, CROs and patient advocates, this will provide a perfect platform to uncover new technologies, processes and solutions to operational challenges when running an oncology trial. The programme will look at the latest challenges and innovations in oncology operations including fostering relationships with clinical sites, innovating data management processes and navigating new regulations impacting oncology trials in the US. Featuring a brand new track on Clinical Technology and Innovation, the conference will be the platform for innovative case studies and break out discussions to connect and enhance your knowledge in the oncology space. Clinical Operations in Oncology is the meeting place for leading pharmaceutical companies and biotechnology institutes. Discover how to excel in oncology operations and clinical supply strategy as well as form key connections for long-term success for your clinical trial. Join us for a two day event filled with case studies, panel discussion and face to face networking opportunities around clinical operations, technology and innovation, and data management.
Read on arena-international.com

Healthcare IT 2023 is honoured and delighted to welcome the Scientists, Engineers, Doctors and consultants, Students from the sector of  healthcare informatics and wellness  to attend our “6th Annual Congress on Wellness and Alternative Healthcare Informatics Which is going to be held on July 11-12, 2023 Paris, France. Theme : “A Step towards for Best Wellness and Healthcare System”. Healthcare IT 2023  that aims to improve health outcomes and healthcare system performance in direct patient care, design and governance of healthcare organizations and therefore the healthcare system, and health information discovery and management, through the applying of technology (hardware, software, and communication). Main objective of this global congress is to promote learning and provide an opportunity to reach the largest assemblage of participants from Wellness and Healthcare informatics companies, research and development community that is from academia, research entities, industrial groups, related associations, societies, Healthcare IT/Software Companies, Health ICT specialist.

Read on healthcareinformatics.insightconferences.com

The 4th RNA Editing Summit returns as the first and only industry-dedicated forum solely focused on the research and therapeutic potential of RNA editing.

Our 2023 event will welcome first disclosures of exciting data with important learnings being communicated so the field can advance toward the clinic. Expect exclusive data from KOLs on the most recent developments in ADAR, APOBEC, CRISPR-Cas13, Cas7-11, and exon editing. Join 80+ thought leaders from the likes of Wave Life Sciences, ProQR, Shape Therapeutics and Korro Bio to stay ahead of the curve and tap into the therapeutic potential of RNA editing and accelerate clinical validation.

Bringing together a new group of RNA editing senior decision makers, a brand new 6-hour workshop day will delve into the key challenges facing RNA editing, including delivery, manufacturing and proof-of-concept.

Read on rnaediting-summit.com